Press

Numinus Wellness Inc. Reports Q2 2023 Results

Apr 14 • 8 min read

Numinus Wellness Inc. (TSX: NUMI / OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced its financial results for the three and six months ended February 28, 2023 (“Q2 2023” and “first six months”). “We are excited about our recently announced training and licensing growth initiatives, which position Numinus as…

atai Life Sciences Announces First Subject Dosed in the Phase 1 IV-to-Subcutaneous Bridging Study of PCN-101 (R-Ketamine)

Apr 14 • 3 min read

atai Life Sciences (NASDAQ: ATAI), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, announced that the first subject has been dosed in Perception Neuroscience’s Phase 1 intravenous-to-subcutaneous bridging study of PCN-101 (R-ketamine). This Phase 1 open-label study is designed to assess the safety, tolerability, and pharmacokinetic profile of 60mg, 90mg and…

Filament Health and Pharmala Biotech Announce Release of GMP MDMA Capsules

Apr 11 • 2 min read

Filament Health Corp. (OTCQB: FLHLF / NEO: FH / FSE: 7QS), a clinical-stage natural psychedelic drug development company, and PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE:MDMA), a Canadian biotechnology company dedicated to the research and development of clinical-grade LaNeo™ MDMA and novel MDXX compounds, today announced the GMP release of MDMA capsules at the Metro Vancouver facility operated…

Nucleus CEO Publishes “Letter from the Captain,” Summarizes Q1 Progress

Apr 11 • 9 min read

Psychedelic Invest’s parent company, Nucleus Holding, Inc. is slated to close its crowdfunding campaign this month. Over on the campaign page at Wefunder, Nucleus CEO Logan Lenz published an update that summarizes how he sees Nucleus positioned amidst the current psychedelics industry. The contents of the letter are also posted below. Hello, I’m Logan, the…

Numinus Launches new Clinic Licensing Platform, the Numinus Network, to Accelerate Expansion

Apr 11 • 4 min read

Numinus Wellness Inc. (TSX: NUMI / OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that it has launched a new clinic licensing model, named the Numinus Network, offering independent practitioners the opportunity to own and operate their own clinic under the trusted Numinus Wellness brand through a licensing…

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435